Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR molecules.
暂无分享,去创建一个
S. H. van der Burg | R. Offringa | J. Drijfhout | C. Melief | A. Geluk | K. V. van Meijgaarden | K. Franken | K. Kwappenberg | T. Ottenhoff | A Geluk | O. Pontesilli | J W Drijfhout | K E van Meijgaarden | R Offringa | E Hovenkamp | E. Hovenkamp | S H van der Burg | K M Kwappenberg | M van der Kruk | O Pontesilli | K L Franken | T H Ottenhoff | C J Melief | M. van der Kruk
[1] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[2] A. Vitiello,et al. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex , 1991, The Journal of experimental medicine.
[3] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.
[4] de Fijter,et al. Increased IL‐10 production by stimulated whole blood cultures in primary IgA nephropathy , 1998, Clinical and experimental immunology.
[5] J. Berzofsky,et al. Cellular immune factors associated with mother‐to-infant transmission of HIV , 1993, AIDS.
[6] A. Trzeciak,et al. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules , 1988, Nature.
[7] N. Nagelkerke,et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya , 1996, The Lancet.
[8] J. Rothbard,et al. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. , 1990, International immunology.
[9] E. Unanue,et al. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. H. van der Burg,et al. Induction of a primary human cytotoxic T‐lymphocyte response against a novel conserved epitope in a functional sequence of HIV‐1 reverse transcriptase , 1995, AIDS.
[11] R. Balderas,et al. Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope‐specific antibodies , 1995, European journal of immunology.
[12] B. Walker,et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. , 1988, Science.
[13] J. Berzofsky,et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. , 1994, JAMA.
[14] A. Rudensky,et al. Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.
[15] R. Offringa,et al. Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. , 1998, Cancer research.
[16] W. Heath,et al. Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help , 1997, The Journal of experimental medicine.
[17] Rob J. De Boer,et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation , 1998, Nature Medicine.
[18] Stephen P. Schoenberger,et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.
[19] A. Lazzarin,et al. Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele , 1997, The Journal of experimental medicine.
[20] J. Berzofsky,et al. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. , 1995, The Journal of clinical investigation.
[21] W. Kast,et al. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Zinkernagel,et al. Peptide-induced antiviral protection by cytotoxic T cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Clerici,et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.
[24] J. Drijfhout,et al. Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs. , 1995, Molecular immunology.
[25] J. Drijfhout,et al. A sensitive fluorometric assay for quantitatively measuring specific peptide binding to HLA class I and class II molecules. , 1997, Journal of immunological methods.
[26] T. Ottenhoff,et al. The impact of DR3 microvariation on peptide binding: the combinations of specific DR beta residues critical to binding differ for different peptides. , 1996, Human immunology.
[27] L. Moretta,et al. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. , 1994, The Journal of infectious diseases.
[28] J. Berzofsky,et al. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope. , 1991, The Journal of infectious diseases.
[29] S. Goff,et al. Structural requirements for bacterial expression of stable, enzymatically active fusion proteins containing the human immunodeficiency virus reverse transcriptase. , 1988, DNA.
[30] M. Baur,et al. Population Analysis on the Basis of Deduced Haplotypes from Random Families , 1984 .
[31] Michel Klein,et al. Changing Virus‐Host Interactions in the Course of HIV‐1 Infection , 1994, Immunological reviews.
[32] H. Rammensee,et al. Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide , 1991, The Journal of experimental medicine.
[33] J. Orange,et al. Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent Pathways , 1998, The Journal of experimental medicine.
[34] J. Forman,et al. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes , 1982, The Journal of experimental medicine.
[35] J. Berzofsky,et al. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[36] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[37] C. Griscelli,et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus‐1‐infected mothers , 1992, European journal of immunology.
[38] J. Wakefield,et al. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome , 1992, Journal of virology.
[39] J. L. Raina,et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. , 1992, Virology.
[40] J. Habeshaw,et al. The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV. , 1991, Journal of immunology.
[41] C. Melief,et al. Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells. , 1995, Leukemia.
[42] C Oseroff,et al. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. , 1994, Immunity.
[43] C. Melief,et al. Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors , 1998, The Journal of experimental medicine.
[44] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant , 1993, The Lancet.
[45] F. Studier,et al. Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.
[46] A. Ferraris,et al. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.